Skip to main content
Top

Drugs

Issue 13/2019

Content (11 Articles)

The Evolving Biomarker Landscape for Treatment Selection in Metastatic Colorectal Cancer

Julien Taieb, Andreas Jung, Andrea Sartore-Bianchi, Marc Peeters, Jenny Seligmann, Aziz Zaanan, Peter Burdon, Clara Montagut, Pierre Laurent-Puig

Take-Home Naloxone for the Emergency Interim Management of Opioid Overdose: The Public Health Application of an Emergency Medicine

John Strang, Rebecca McDonald, Gabrielle Campbell, Louisa Degenhardt, Suzanne Nielsen, Alison Ritter, Ola Dale

Pharmacotherapies for the Treatment of Eosinophilic Esophagitis: State of the Art Review

Willemijn E. de Rooij, Evan S. Dellon, Claire E. Parker, Brian G. Feagan, Vipul Jairath, Christopher Ma, Albert J. Bredenoord

Glycopyrronium/Formoterol: A Review in COPD

Zaina T. Al-Salama, James E. Frampton

Polatuzumab Vedotin: First Global Approval

Emma D. Deeks

Entrectinib: First Global Approval

  • NSCLC
  • AdisInsight Report

Zaina T. Al-Salama, Susan J. Keam

Selinexor: First Global Approval

Yahiya Y. Syed

Correction to: Damoctocog Alfa Pegol: A Review in Haemophilia A

Julia Paik, Emma D. Deeks

Correction to: Camrelizumab: First Global Approval

Anthony Markham, Susan J. Keam

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images